APIC BIO
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing several novel gene therapies to treat Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS), and other CNS diseases.
APIC BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.apic-bio.com
Total Employee:
11+
Status:
Active
Contact:
(857) 302-3757
Email Addresses:
[email protected]
Total Funding:
53.32 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API LetsEncrypt SSL By Default Apache Person Schema Unified Layer Comcast
Similar Organizations
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Biophytis
Biophytis is a research company that focuses on the fields of metabolic and age-related diseases.
Bioz
Bioz is a disruptive startup at the intersection of information technology and scientific research.
Dren Bio
Dren Bio focuses on protein engineering technologies for depletion of cells, protein aggregates, and other disease-causing agents.
GentiBio
GentiBio is a biotherapeutics company developing engineered regulatory T cells programmed to treat autoimmune allergic diseases.
New Amsterdam Pharma
New Amsterdam is a clinical-stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
NKGen Biotech
NKGen Biotech is restoring immune function through the development of unique natural killer (NK) cell therapies for the treatment of cancer.
Toregem BioPharma
Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia.
VectorY
VectorY is an integrated gene therapy company focused on development of therapeutics for CNS, somatic disorders and muscle diseases.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Apic Bio
ALS Investment Fund
ALS Investment Fund investment in Series A - Apic Bio
Alpha-1 Foundation
Alpha-1 Foundation investment in Seed Round - Apic Bio
Edward Krapels
Edward Krapels investment in Seed Round - Apic Bio
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-01-17 | MabPlex International | Apic Bio investment in Series A - MabPlex International | 400 M CNY |
Official Site Inspections
http://www.apic-bio.com Semrush global rank: 13.36 M Semrush visits lastest month: 78
- Host name: fossil02.parklogic.com
- IP address: 172.234.222.143
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Apic Bio"
Apic Bio - Crunchbase Company Profile & Funding
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases. The company is advancing several novel gene therapies to treat Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic …See details»
Apic Bio Company Profile 2024: Valuation, Funding
Apic Bio General Information Description. Operator of a gene therapy company intended to help patients find a cure for genetic diseases. The company's platform utilizes a single vector to silence and replace damaged genes, enabling …See details»
Apic Bio - Funding, Financials, Valuation & Investors - Crunchbase
Jan 17, 2019 Seed Round - Apic Bio — Investments. Edit Investments Section. Number of Investments 1. Apic Bio has invested in MabPlex International on Jan 17, 2019. This …See details»
Apic Bio Company Profile - Office Locations, Competitors ... - Craft
Apic Bio is a gene therapy company that is engaged in finding cures for patients with devastating neurological and liver genetic diseases. The Company's pipeline focuses on treatments for …See details»
Apic Bio - Contacts, Employees, Board Members, Advisors & Alumni
Apic Bio has 5 current employee profiles, including Interim Chief Financial Officer Daniel Geffken. Apic Bio has 2 board members and advisors, including Jason Dinges. Contacts. Edit Contacts …See details»
Apic Bio - Overview, News & Similar companies | ZoomInfo.com
Jan 5, 2021 Apic Bio Receives FDA Fast Track Designation for APB-102 for the Treatment of Patients with SOD1 ALS CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apic Bio, Inc., an …See details»
Scott Loiler - President & CTO at Apic Bio - The Org
At Apic, Scott oversees the development of Adeno-associated virus (AAV) vectors from research scale to GMP production for use in Apic’s pre-clinical and clinical studies as well as new technology. Scott holds a Ph.D. in Virology and …See details»
Apic Bio - The Org
Apic Bio is committed to finding cures for patients with genetic diseases.See details»
UMass gene therapy spin-off Apic Bio launches - Chemical
Apic Bio, a spin-off from the University of Massachusetts Medical School, has raised $40 million in series A financing to develop gene therapies for people with the neurodegenerative disease ...See details»
Apic Bio Announces FDA Clearance of IND Application for Lead …
Apr 22, 2021 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
Apic Bio Completes $40 Million Financing to Advance …
Jan 7, 2019 Apic Bio said it completed a $40 million financing to advance its experimental gene therapy programs and support additional discovery efforts. Morningside Venture Investments led the round. The ALS Investment Fund …See details»
Apic Bio Announces $40M Series A Financing to Advance Novel …
Jan 7, 2019 About Apic Bio Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School …See details»
FDA clears Investigational New Drug application for ALS gene …
Apr 21, 2021 Apic Bio, a gene therapy company developing treatment options for patients with rare genetic diseases and co-founded by UMass Medical School’s Robert H. Brown Jr., DPhil, …See details»
Apic Bio - Updates, News, Events, Signals & Triggers - Crunchbase
Apic Bio is engaged in the development of gene therapy solutions, focusing on the use of AAV vector packaging platforms. Their research includes the creation of helper plasmids that …See details»
uniQure and Apic Bio enter into global licensing agreement
Jan 31, 2023 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
Apic Bio Launches to Advance First-in-Class Gene ... - Business Wire
Aug 22, 2017 About Apic Bio: Apic Bio, Inc. is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by its …See details»
Apic Bio Announces FDA Clearance of IND Application for Lead …
Apr 21, 2021 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
uniQure signs licence deal for Apic Bio’s gene therapy for ALS
May 10, 2023 Gene therapy company UniQure has entered a global licensing agreement with Apic Bio for APB-102 to treat patients with amyotrophic lateral sclerosis (ALS) caused by …See details»
Apic Bio Receives FDA Fast Track Designation for APB-102 for the ...
Jul 28, 2021 Apic Bio is an innovative gene therapy company focused on developing first-in-class treatment options for rare, undertreated neurological and liver diseases. The Company’s …See details»
APIC BIO: Apic Bio’s APB-102 Receives Orphan Drug Designation …
Jul 22, 2019 Apic Bio issued the following announcement on July 22. Apic Bio, Inc., an innovative gene therapy company developing novel treatment options for patients with rare …See details»